annual shareholders equity:
$228.84M+$33.41M(+17.10%)Summary
- As of today (August 16, 2025), COLL annual stockholders equity is $228.84 million, with the most recent change of +$33.41 million (+17.10%) on December 31, 2024.
- During the last 3 years, COLL annual shareholders equity has risen by +$25.91 million (+12.77%).
- COLL annual shareholders equity is now at all-time high.
Performance
COLL Shareholders equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly shareholders equity:
$232.21M-$2.23M(-0.95%)Summary
- As of today (August 16, 2025), COLL quarterly stockholders equity is $232.21 million, with the most recent change of -$2.23 million (-0.95%) on June 1, 2025.
- Over the past year, COLL quarterly shareholders equity has increased by +$15.62 million (+7.21%).
- COLL quarterly shareholders equity is now -8.24% below its all-time high of $253.07 million, reached on June 30, 2021.
Performance
COLL quarterly shareholders equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Shareholders equity Formula
Shareholders Equity = Total Assets − Total Liabilities
COLL Shareholders equity Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +17.1% | +7.2% |
3 y3 years | +12.8% | +17.5% |
5 y5 years | +161.7% | +49.1% |
COLL Shareholders equity Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +17.4% | -0.9% | +29.8% |
5 y | 5-year | at high | +161.7% | -8.2% | +49.1% |
alltime | all time | at high | +356.1% | -8.2% | +1997.0% |
COLL Shareholders equity History
Date | Annual | Quarterly |
---|---|---|
Jun 2025 | - | $232.21M(-1.0%) |
Mar 2025 | - | $234.43M(+2.4%) |
Dec 2024 | $228.84M(+17.1%) | $228.84M(-2.3%) |
Sep 2024 | - | $234.28M(+8.2%) |
Jun 2024 | - | $216.58M(-2.5%) |
Mar 2024 | - | $222.17M(+13.7%) |
Dec 2023 | $195.43M(+0.3%) | $195.43M(+9.3%) |
Sep 2023 | - | $178.87M(-10.9%) |
Jun 2023 | - | $200.81M(+11.7%) |
Mar 2023 | - | $179.73M(-7.8%) |
Dec 2022 | $194.84M(-4.0%) | $194.84M(-1.2%) |
Sep 2022 | - | $197.19M(-0.2%) |
Jun 2022 | - | $197.61M(+0.8%) |
Mar 2022 | - | $196.08M(-3.4%) |
Dec 2021 | $202.93M(+9.1%) | $202.93M(-19.2%) |
Sep 2021 | - | $251.09M(-0.8%) |
Jun 2021 | - | $253.07M(+48.8%) |
Mar 2021 | - | $170.03M(-8.6%) |
Dec 2020 | $186.03M(+112.8%) | $186.03M(+7.7%) |
Sep 2020 | - | $172.69M(+10.9%) |
Jun 2020 | - | $155.77M(+10.4%) |
Mar 2020 | - | $141.06M(+61.3%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2019 | $87.43M(-4.5%) | $87.43M(+3.8%) |
Sep 2019 | - | $84.26M(-1.8%) |
Jun 2019 | - | $85.82M(-0.6%) |
Mar 2019 | - | $86.35M(-5.7%) |
Dec 2018 | $91.58M(-12.0%) | $91.58M(+29.4%) |
Sep 2018 | - | $70.78M(-14.4%) |
Jun 2018 | - | $82.68M(-9.0%) |
Mar 2018 | - | $90.82M(-12.7%) |
Dec 2017 | $104.08M(-22.9%) | $104.08M(+8.1%) |
Sep 2017 | - | $96.27M(+0.8%) |
Jun 2017 | - | $95.51M(-16.5%) |
Mar 2017 | - | $114.37M(-15.2%) |
Dec 2016 | $134.91M(+58.6%) | $134.91M(+81.5%) |
Sep 2016 | - | $74.33M(-24.7%) |
Jun 2016 | - | $98.66M(-19.0%) |
Mar 2016 | - | $121.74M(+43.1%) |
Dec 2015 | $85.07M(-195.2%) | $85.07M(-9.1%) |
Sep 2015 | - | $93.56M(-8.6%) |
Jun 2015 | - | $102.42M(+197.3%) |
Mar 2015 | - | $34.45M(-381.4%) |
Dec 2014 | -$89.35M(+31.0%) | -$12.24M |
Dec 2013 | -$68.22M | - |
FAQ
- What is Collegium Pharmaceutical, Inc. annual stockholders equity?
- What is the all time high annual shareholders equity for Collegium Pharmaceutical, Inc.?
- What is Collegium Pharmaceutical, Inc. annual shareholders equity year-on-year change?
- What is Collegium Pharmaceutical, Inc. quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Collegium Pharmaceutical, Inc.?
- What is Collegium Pharmaceutical, Inc. quarterly shareholders equity year-on-year change?
What is Collegium Pharmaceutical, Inc. annual stockholders equity?
The current annual shareholders equity of COLL is $228.84M
What is the all time high annual shareholders equity for Collegium Pharmaceutical, Inc.?
Collegium Pharmaceutical, Inc. all-time high annual stockholders equity is $228.84M
What is Collegium Pharmaceutical, Inc. annual shareholders equity year-on-year change?
Over the past year, COLL annual stockholders equity has changed by +$33.41M (+17.10%)
What is Collegium Pharmaceutical, Inc. quarterly stockholders equity?
The current quarterly shareholders equity of COLL is $232.21M
What is the all time high quarterly shareholders equity for Collegium Pharmaceutical, Inc.?
Collegium Pharmaceutical, Inc. all-time high quarterly stockholders equity is $253.07M
What is Collegium Pharmaceutical, Inc. quarterly shareholders equity year-on-year change?
Over the past year, COLL quarterly stockholders equity has changed by +$15.62M (+7.21%)